Can Acipimox Reduce Serum Lipoprotein(a) Levels in Hemodialyzed Patients?

Publisher： Karger

E-ISSN： 2235-3186|78|4|489-489

ISSN： 1660-8151

Source： Nephron, Vol.78, Iss.4, 1998-03, pp. : 489-489

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Plasma Lipoprotein(a) Levels and Atherosclerotic Renal Artery Stenosis in Hypertensive Patients

By  

Kidney and Blood Pressure Research, Vol. 40, Iss. 2, 2015-03 ,pp. : 166-175

Karger

Access to resources Recommend Favorite

Serum Prohepcidin and Hepcidin in Hemodialyzed Patients Undergoing Iron Therapy

By  

Kidney and Blood Pressure Research, Vol. 32, Iss. 4, 2009-08 ,pp. : 235-238

Karger

Access to resources Recommend Favorite

Renin-Angiotensin System Inhibitors Reduce Serum Asymmetric Dimethylarginine Levels and Oxidative Stress in Normotensive Patients with Chronic Kidney Disease

By  

Nephron Extra, Vol. 4, Iss. 1, 2014-02 ,pp. : 18-25

Karger

Access to resources Recommend Favorite

Serum Crosslaps Correlations with Serum ICTP and Urine DPD in Hemodialyzed and Peritoneally Dialyzed Patients

By  

Nephron, Vol. 87, Iss. 3, 2001-03 ,pp. : 283-285

Karger

Access to resources Recommend Favorite

Leptin and Serum Erythropoietin in Hemodialyzed and Peritoneally Dialyzed Uremic Patients during rHuEPO Therapy

By  

American Journal of Nephrology, Vol. 20, Iss. 3, 2000-06 ,pp. : 180-186

Karger

Access to resources Recommend Favorite